Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin). Leuk Lymphoma 2006 Feb;47(2):373-5
Date
12/03/2005Pubmed ID
16321875DOI
10.1080/10428190500282019Scopus ID
2-s2.0-30644461685 (requires institutional sign-in at Scopus site) 5 CitationsAuthor List
Braiteh F, Ng C, Kurzrock RAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAntibiotics, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow Transplantation
Combined Modality Therapy
Drug Administration Schedule
Hodgkin Disease
Humans
Infusions, Intravenous
Male
Neoplasm Staging
Pentostatin
Positron-Emission Tomography
Recurrence
Remission Induction
Sensitivity and Specificity
Transplantation, Autologous
Treatment Outcome